MeSH D010035 - suppurative otitis media
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Ofloxacin | Ofloxacin | 2003-09-02 | |||
| Johnson & Johnson | Ofloxacin | Floxin | 1990-12-28 | |||
| Sandoz | Ofloxacin | Ofloxacin | 2004-05-14 | |||
| Bausch Health Companies | Ofloxacin | Ofloxacin | 2008-03-17 | |||
| Allergan | Ofloxacin | Ocuflox | 1993-07-30 | |||
| Dr Reddys Laboratories | Ofloxacin | Ofloxacin | 2006-02-10 | |||
| Apotex | Ofloxacin | Ofloxacin | 2004-05-14 | |||
| Amneal Pharmaceuticals | Ofloxacin | Ofloxacin | 2019-08-30 | |||
| Alvogen | Ofloxacin | Ofloxacin | 2004-08-31 | |||
| Cadila Pharmaceuticals | Ofloxacin | Ofloxacin | 2014-09-18 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/1
Phase 2
0%0/0
Phase 3
20%1/5
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use